Diclofenac potassium 25 MG Oral Tablet — RxCUI 857702
RxNorm drug concept · Semantic clinical drug
RxCUI 857702
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI857702
Official nameDiclofenac potassium 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDiclofenac K+ 25 MG Oral Tablet; Diclofenac Pot 25 MG Oral Tablet
FDA products mapped14
Package NDCs mapped29
Reported Medicaid activity (SDUD)76,793 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diclofenac Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- They calm inflammation after cataract surgery. They also temporarily ease pain and light sensitivity after corneal refractive surgery, such as PRK or radial keratotomy.
- After cataract surgery, it is usually about 4 times a day, starting the day after surgery for the first 2 weeks. For refractive surgery, you use drops before and right after the pr...
- Brief burning or stinging is the most common complaint, affecting about 15% of people. It usually passes quickly. Tell your doctor if it persists or you notice blurred vision, redn...
- Be careful and tell your doctor first. People sensitive to aspirin or other NSAIDs may also react to diclofenac. You should not use the drops if you are allergic to any ingredient...
🕸️ Concept Web — How Diclofenac potassium 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Diclofenac potassium 25 MG Oral Tablet
RxCUI 857702 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Diclofenac
3355IN -
Diclofenac potassium
81997PIN
-
Diclofenac
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lofena
2584345BN
-
Lofena
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Diclofenac Oral Tablet
371798SCDF -
Diclofenac potassium Oral Tablet
2645527SCDFP -
Diclofenac Oral Product
1151152SCDG -
Diclofenac Pill
1151153SCDG -
Diclofenac potassium Oral Product
2670604SCDGP -
Diclofenac potassium Pill
2670605SCDGP -
Diclofenac Oral Tablet [Lofena]
2584349SBDF -
Diclofenac potassium Oral Tablet [Lofena]
2654561SBDFP - +5 more in this family
-
Diclofenac Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Diclofenac potassium 25 MG
857701SCDC -
Diclofenac potassium 25 MG Oral Tablet [Lofena]
2584350SBD -
Diclofenac potassium 25 MG [Lofena]
2584346SBDC
-
Diclofenac potassium 25 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Diclofenac potassium 25 MG
SCDC · 857701 -
Diclofenac Oral Tablet
SCDF · 371798 -
Diclofenac potassium Oral Tablet
SCDFP · 2645527 -
Diclofenac Oral Product
SCDG · 1151152 -
Diclofenac Pill
SCDG · 1151153 -
Diclofenac potassium Oral Product
SCDGP · 2670604 -
Diclofenac potassium Pill
SCDGP · 2670605
Brand-Name Concepts
-
Diclofenac potassium 25 MG Oral Tablet [Lofena]
SBD · 2584350 -
Diclofenac potassium 25 MG [Lofena]
SBDC · 2584346 -
Diclofenac Oral Tablet [Lofena]
SBDF · 2584349 -
Diclofenac potassium Oral Tablet [Lofena]
SBDFP · 2654561 -
Lofena Oral Product
SBDG · 2584347 -
Lofena Pill
SBDG · 2584348 -
Lofena
BN · 2584345
📦 FDA Products & Package NDCs
14 products · 29 package NDCs
29 package NDCs map to RxCUI 857702 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 15370-0180-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (15370-180-10) | LOFENA | Carwin Pharmaceutical Associates, LLC | 2021-10-25 |
| 15370-0180-60 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (15370-180-60) | LOFENA | Carwin Pharmaceutical Associates, LLC | 2021-10-25 |
| 15370-0185-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (15370-185-30) | Diclofenac Potassium | Carwin Pharmaceutical Associates, LLC | 2023-11-01 |
| 15370-0185-60 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (15370-185-60) | Diclofenac Potassium | Carwin Pharmaceutical Associates, LLC | 2025-04-08 |
| 24470-0924-60 | 60 TABLET in 1 BOTTLE (24470-924-60) | DICLOFENAC POTASSIUM | Cintex Services, LLC | 2023-12-19 |
| 60290-0057-01 | 100 TABLET, FILM COATED in 1 BOTTLE (60290-057-01) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2022-05-12 |
| 60290-0057-02 | 1000 TABLET, FILM COATED in 1 BOTTLE (60290-057-02) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2022-05-12 |
| 60290-0057-03 | 500 TABLET, FILM COATED in 1 BOTTLE (60290-057-03) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2022-05-12 |
| 60290-0088-01 | 30 TABLET, FILM COATED in 1 BOTTLE (60290-088-01) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2024-09-28 |
| 60290-0088-02 | 100 TABLET, FILM COATED in 1 BOTTLE (60290-088-02) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2024-09-28 |
| 60290-0088-03 | 500 TABLET, FILM COATED in 1 BOTTLE (60290-088-03) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2024-09-28 |
| 60290-0088-04 | 1000 TABLET, FILM COATED in 1 BOTTLE (60290-088-04) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2024-09-28 |
| 60290-0088-05 | 60 TABLET, FILM COATED in 1 BOTTLE (60290-088-05) | Diclofenac Potassium | Umedica Laboratories USA Inc. | 2025-10-30 |
| 69292-0548-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69292-548-30) | Diclofenac Potassium | Amici Pharma Inc. | 2024-04-18 |
| 69292-0550-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69292-550-01) | Diclofenac Potassium | Amici Pharma Inc. | 2020-12-11 |
| 72888-0073-00 | 1000 TABLET, COATED in 1 BOTTLE (72888-073-00) | Diclofenac Potassium | Advagen Pharma Ltd | 2020-12-19 |
| 72888-0073-01 | 100 TABLET, COATED in 1 BOTTLE (72888-073-01) | Diclofenac Potassium | Advagen Pharma Ltd | 2020-12-19 |
| 72888-0073-05 | 500 TABLET, COATED in 1 BOTTLE (72888-073-05) | Diclofenac Potassium | Advagen Pharma Ltd | 2022-02-03 |
| 72888-0073-30 | 30 TABLET, COATED in 1 BOTTLE (72888-073-30) | Diclofenac Potassium | Advagen Pharma Ltd | 2020-12-19 |
| 72888-0086-00 | 1000 TABLET, COATED in 1 BOTTLE (72888-086-00) | Diclofenac Potassium | Advagen Pharma Ltd | 2021-03-16 |
| 72888-0086-01 | 100 TABLET, COATED in 1 BOTTLE (72888-086-01) | Diclofenac Potassium | Advagen Pharma Ltd | 2021-03-16 |
| 72888-0086-30 | 30 TABLET, COATED in 1 BOTTLE (72888-086-30) | Diclofenac Potassium | Advagen Pharma Ltd | 2021-03-16 |
| 73352-0086-30 | 30 TABLET, COATED in 1 BOTTLE (73352-086-30) | Diclofenac Potassium | Trifluent Pharma LLC | 2023-02-17 |
| 73352-0086-60 | 60 TABLET, COATED in 1 BOTTLE (73352-086-60) | Diclofenac Potassium | Trifluent Pharma LLC | 2023-09-25 |
| 74157-0007-60 | 60 TABLET, COATED in 1 BOTTLE (74157-007-60) | Diclofenac Potassium | INA Pharmaceutics Inc | 2021-09-20 |
| 74157-0016-60 | 60 TABLET in 1 BOTTLE (74157-016-60) | DICLOFENAC POTASSIUM | INA Pharmaceutics Inc, | 2024-10-01 |
| 75834-0337-30 | 30 TABLET, FILM COATED in 1 BOTTLE (75834-337-30) | Diclofenac Potassium | NIVAGEN PHARMACEUTICALS, INC. | 2025-10-10 |
| 75834-0337-60 | 60 TABLET, FILM COATED in 1 BOTTLE (75834-337-60) | Diclofenac Potassium | NIVAGEN PHARMACEUTICALS, INC. | 2025-10-10 |
| 87127-0802-60 | 60 TABLET in 1 BOTTLE (87127-802-60) | DICLOFENAC POTASSIUM | Happy Robin, LLC | 2025-09-24 |
Observed labelers:
Umedica Laboratories USA Inc. (8) ·
Advagen Pharma Ltd (7) ·
Carwin Pharmaceutical Associates, LLC (4) ·
Amici Pharma Inc. (2) ·
NIVAGEN PHARMACEUTICALS, INC. (2) ·
Trifluent Pharma LLC (2)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.